High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Background: Colorectal cancer is the third most common cancer in both sex worldwide and it is also the fourth most common cause of cancer mortality. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yu-Feng, Hsieh, Pei-Ling, Lin, Ching-Yih, Sun, Ding-Ping, Sheu, Ming-Jen, Yang, Ching-Chieh, Lin, Li-Ching, He, Hong-Lin, Solórzano, Julia, Li, Chien-Feng, Chang, I-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463434/
https://www.ncbi.nlm.nih.gov/pubmed/28607594
http://dx.doi.org/10.7150/jca.18197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463434/
https://www.ncbi.nlm.nih.gov/pubmed/28607594
http://dx.doi.org/10.7150/jca.18197

Ejemplares similares